Vincent Pieribone

Professor & Fellow
The John B. Pierce Laboratory, Inc./Yale University

Vincent Pieribone, Professor, Yale University School of Medicine; Director and Fellow, The John. B. Pierce Laboratory. Dr. Pieribone received a Bachelor of Arts in biology and chemistry from the New York University College of Arts and Sciences in 1986, and a Ph.D. in neuroanatomy and neurophysiology from New York University’s Graduate School of Arts and Sciences in 1992. From 1990 to 1992 he was a National Science Foundation and National Institutes of Health Fogarty International Fellow at the Nobel Institute of Neurophysiology at the Karolinska Institute in Stockholm, Sweden. Dr. Pieribone completed postdoctoral work at The Rockefeller University in New York from 1992 to 1995 with Dr. Paul Greengard and became an Assistant Professor there in 1995. He joined the Pierce Laboratory and the Departments of Molecular and Cellular Physiology and Neuroscience at Yale University in 1998 and became a full Fellow and Full Professor in 2013. In 2017 he became the Director of The John B. Pierce Laboratory, Inc. He is a Visiting Scientist at Mystic Aquarium and The Museum of Natural History. He has produced over 100 original scientific publications, co-authored the book “Aglow in the Dark: the Revolutionary Science of Biofluorescence.” (Harvard Press; 2005) and has several issued patents. He has founded two biomedical companies (Marinus Pharmaceuticals (NASDAQ; MRNS) and Affinimark Technologies, Inc. Dr. Pieribone’s laboratory is focused on the development of novel methods which allow widespread optical capture of brain electrical activity. Towards this end he focuses on three areas: i) Engineering protein-based optical voltage indicators, ii) engineering mobile high-speed optical brain/computer interfaces – for recording brain electrical activity, and iii) identification of novel fluorescent and bioluminescent systems from marine organisms- for incorporation into in vivo activity indicator molecules. His research is supported by the National Institutes of Health, The National Science Foundation and the Defense Advanced Research Projects Agency (DARPA). In 2016 he became the Vice Chairman of the OceanX.